Endovascular Procedures
All endovascular procedures were performed using a biplane angiography unit with 3-dimensional rotational angiography capability (Axiom Artis Zee Biplane; Siemens, Erlangen, Germany). For patients with unruptured aneurysms, dual antiplatelet drugs [300 mg/day aspirin and 75 mg/day clopidogrel (Plavix;
Sanofi-Synthelabo, Seoul, Korea)] were given for at least 3 days before the procedure. For patients with ruptured aneurysms, Tirofiban (Aggrastat, Merck & Co, Whitehouse Station, NJ, USA) was started after the aneurysms were secured with the coil.
In our institution, since June 2012 platelet inhibition function has been performed with the Multiplate ® analyzer system (Dynabyte Medical, Munich, Germany) immediately before starting the procedure. If the patient was considered as a nonresponder [> 45 units (U) for the area under the curve of clopidogrel or > 30 U for that of aspirin], an additional anti-platelet drug was administered as soon as the procedure was finished.
All of the procedures were performed under local anesthesia. Boston Scientific, Natick, MA, USA) was first navigated and positioned across the aneurysm neck. The stent was then loaded into the microcatheter and deployed by withdrawing the microcatheter while stabilizing the delivering wire. Three stenting strategies were employed in this study: the mesh technique, the jailing technique, and the salvaging stent placement (12) . At the end of coiling, final angiographic images were acquired to confirm adequate coiling.
After the procedure, low-molecular-weight heparin (2850 IU/0.3 mL) (Fraxiparine; Sanofi-Synthelabo, Seoul, Korea) was administered subcutaneously for 2 days. All the patients were contin-result in different appearances of the parent artery and stent itself (10) . The distal internal carotid artery (ICA), and especially the carotid siphon, is known to have a tortuous vasculature, as the name suggests. Thus stent deployment for the distal ICA including the carotid siphon involves a complicated anatomical region and might result in more complications during and after the stent deployment procedure.
Follow-up imaging after stent-assisted coil embolization (SACE) procedures has usually been focused on the presence or absence of residual filling in the aneurysm (7, 11) . To our knowledge, no published studies have included an evaluation of the angiographic follow-up results focused on the distal ICA as the parent artery and comparison of the stent-deployment effects between these two stents in the SACE of distal ICA aneurysms.
In this study, we retrospectively analyzed and compared the follow-up angiographic results of distal ICA aneurysms including the carotid siphon, treated by a SACE technique using the Enterprise or the Neuroform. We discuss the stent-associated effects, focusing on the angiographic findings of the parent artery.
MATERIALS AND METHODS

Patients
This study was approved by the institutional review board at our institution. Informed consent from patients was waived due to the retrospective study design.
Imaging data of distal ICA aneurysms treated with SACE from December 2008 to September 2012 were analyzed in this retrospective study. Inclusion criteria were: 1) the location of the stent within the distal ICA, including the paraclinoid ICA, the carotid siphon; 2) the availability of immediate post-implantation digital subtraction angiography (DSA) and follow-up DSA images from 6 months after the stent implantation, from February 2009 to April 2013; 3) the use of a self-expanding nitinol intracranial stent: the Enterprise or the Neuroform stent (4.5 mm in diameter by 28 mm in length for the Enterprise and 4.5 mm in diameter by 20 mm in length for the Neuroform); 4) single deployment of the stent for one parent artery (two or more stent insertions for the same side of the parent artery were excluded).
We reviewed our database for cases of aneurysms treated by SACE and found 68 patients with 70 aneurysms that met these jksronline.org 
Clinical Evaluation
The patients' medical histories, procedural reports, and clinical outcomes were analyzed retrospectively by reviewing their electronic medical record charts. A complete neurologic examination was performed on all patients by a neurosurgeon, at the baseline, and immediately after the procedure and at the followup by experienced physicians certified in stroke assessment. A modified Rankin scale (mRS) score (14) was assessed at the follow-up evaluations. Any adverse events, especially ischemic stroke events, were checked and recorded.
Statistical Analyses
All data were presented as mean ± standard deviation. Fisher's exact test was used for comparisons of categorical data. Student's t-test was used to determine statistical significance for continuous parameters including age, aneurysm size, stent-substented arc angle, carotid siphon angle, and significant in-stent stenosis.
Significant differences were established for p < 0.05. Statistical analysis was performed by using MedCalc (version 12.7.0., MedCalc Software, Mariakerke, Belgium).
RESULTS
Patients
In total, 68 patients with 70 aneurysms were available for analysis. The patients' mean age was 54.9 ± 10.7 years (range, 26-78 years), including 16 men and 52 women. Patient demographic information and aneurysm characteristics are provided in Table 1 .
Follow-up DSA images were performed for all patients, ranging from 6 to 36 months (mean 9.1 ± 4.7 months) after the initial stent-assisted coiling procedure. Most of the patients (66/68) had unilateral (right or left) stent insertion. However, 2 patients had bilateral Enterprise stent insertion for coiling of each side of distal ICA aneurysms. ued on aspirin and clopidogrel postoperatively for 6 months to 1 year, depending on the patient's condition.
Follow-Up and Image Analysis
All patients were followed up with DSA beyond 6 months after the initial SACE procedure. Angiograms were performed at high magnification in the working angles for the coil embolization and the stenting. Working angles were reproduced by optimizing the orientation of osseous landmarks with the stent markers and coil mass.
Follow-up DSA images were then compared with the immediate post-embolization angiograms with a similar projection and the same magnification ratio for the following parameters.
1) The term "intraluminal filling defect" was defined as a focal contrast filling defect at the stent-deployment area of the parent artery, between the stent filament and the vessel wall in the follow-up angiogram only (the "intraluminal filling defect" did not appear in the initial immediate post-embolization angiogram).
And the presence of an incomplete intraluminal filling defect was recorded.
2) The stent-subtended arc angle, measured independently of the radius of the siphon curvature, was evaluated on the basis of the angle at which the stent was deployed in the parent vessel (7) .
3) The carotid siphon angle was measured by the following method: first, the center was placed at the midpoint of the carotid siphon; second, a line was drawn between the center point and upper and lower portion of the carotid siphon; finally the angle between the two lines was measured.
4) The term "straightening" was defined as more than 10% of an angle increase of the parent artery between the immediate postembolization angiograms and the follow-up angiograms, using the stent-subtended arc angle and carotid siphon angle.
5)
The mean diameter at the distal and proximal portion of the stent-deployment sites was measured to identify in-stent stenosis (or intimal hyperplasia). We defined the term "significant in-stent stenosis" as indicating more than 50% narrowing within the stent-deployment area of the parent artery. Angiographic results are summarized in Table 2 .
Aneurysm Occlusion Grade
On the immediate post-treatment angiogram, the occlusion grades were as follows for the Enterprise group: RS 1 in 23 (74.2%), (20.5%) cases in the Neuroform group (Fig. 3 ). Among the 70 deployed stents, 2 Enterprise stents showed delayed migration on the follow-up images, but the length of migration was < 10 mm. Table 3 .
Clinical Outcome
In the Enterprise group with unruptured aneurysms (n = 26), none of the patients had neurologic symptoms at the baseline or at the follow-up. In the Enterprise group with ruptured aneurysms (n = 3), one patient (3.4%) showed mild lower extremity numbness (mRS = 1) at the follow-up. In the Neuroform group with unruptured aneurysms (n = 37), none of the patients except two had neurologic symptoms at the baseline. One patient (2.6%), who had been previously diagnosed with poliomyelitis, had left leg weakness (mRS = 2) at the baseline. Another patient (2.6%) initially had gait disturbance and weakness (mRS = 3) due to a previous cerebral infarction. At the follow-up, these two patients showed no additional neurologic symptoms. In the Neuroform group with ruptured aneurysms (n = 2), these two patients had severe headache and mental changes at the baseline but after treatment and at the follow-up, they showed no neurologic symptoms. (22) .
DISCUSSION
There are several reports on the morphological changes, particularly conformity of the parent artery, after stent deployment (1, 7, 9, 10, 23, 24) . In our study, the Enterprise group with ISA showed no additional neurologic symptoms at follow-up. To demonstrate the clinical significance of ISA in cases treated with Enterprise devices, further studies will be needed.
Second, after stent deployment, activation and proliferation of regional smooth muscle cells develops and may lead to neointimal hyperplasia, which can cause a re-stenosis within the stent (25, 26) .
Endothelial cells have a critical role in the control of smooth muscle growth, and when regulation is disturbed, neointimal hyperplasia causes stenosis (25, 27) . In-stent stenosis is commonly encountered within 3-6 months after stent deployment (25, 28, 29) . Some histopathologic reports have demonstrated that neointimal hyperplasia is implicated as the primary mechanism in in-stent stenosis (25, 30, 31) . In our study, there was no significant in-stent stenosis in either of the two groups. There was no statistically significant difference between the two stents in the occurrence of significant in-stent stenosis (0% and 0%, respectively, p = 1). In our study, no patient showed any significant neu- First, only the Enterprise group showed intraluminal filling defects of the parent artery (n = 6/31, 19.4%). Our results showed a statistically significant greater occurrence of intraluminal filling defects using the Enterprise compared with using the Neuroform (19.4% and 0%, respectively, p = 0.0056). We thought that incomplete stent apposition (ISA), defined as separation of one or more stent struts from the underlying vessel wall and observation of blood speckles between the stent struts and the vessel wall (19) , and foreign body reaction around the struts (20) A further study by Heller et al. (7) showed that the high prevjksronline.org In our study, the occurrence of straightening between the Enterprise and the Neuroform was not significantly different (35.5% and 20.5%, respectively, p = 0.1856).
Fourth, there have been reports of delayed migration related to the Enterprise stent (9, (33) (34) (35) . According to the literature, possible explanations for this delayed migration include the inherited structural characteristics of the Enterprise, the diameter difference between either side of the stent-deployed vessels, and the angle formed between the locations proximal and distal to the stent expanding after stent placement. Similarly to a previous study (9) , we found the phenomenon of angle expansion, defined as straightening in our study, associated with the use of not only the Enterprise stent but also the Neuroform stent. After angular expansion, the stented segment of the distal portion may develop closer in line with the proximal portion, thus decreasing resistance of stent migration proximally. In our study, delayed migrations were seen only with the Enterprise stent.
Our initial angiographic results showed that 62/70 (88.6%) of aneurysms treated with SACE had total occlusion (RS 1) or only minimal flow into the neck (RS 2) (Table 3) , and follow-up angiograms showed 67/70 (95.7%) of aneurysms had no flow or only minimal flow into the neck of the aneurysms. Consistent with previous reports (11, 18, (36) (37) (38) , initial subtotal occlusion tends to progress to total occlusion in either type of stent.
There were several limitations in this study. First, the study was retrospective in nature with the possibility of selection bias.
Second, the number of patients was relatively small. Further studies are required with a larger number of cases and adequate follow-up to identify whether the long-term outcome of endovascular treatment is affected by vascular configuration change.
Third, in this study, the measurements were acquired from selected 2-dimensional projection angiographic images using the PACS workstation. As mentioned by the authors of a previous study (1, 23) , it is very difficult to describe the morphologic
